Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy

Over the past decade different stem cell (SC) based approaches were tested to treat Duchenne Muscular Dystrophy (DMD), a lethal X-linked disorder caused by mutations in dystrophin gene. Despite research efforts, there is no curative therapy for DMD. Allogeneic SC therapies aim to restore dystrophin...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemionow, M., Cwykiel, J., Heydemann, A., Garcia-Martinez, J., Siemionow, K., Szilagyi, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887005/
https://www.ncbi.nlm.nih.gov/pubmed/29305755
http://dx.doi.org/10.1007/s12015-017-9792-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887005/
https://www.ncbi.nlm.nih.gov/pubmed/29305755
http://dx.doi.org/10.1007/s12015-017-9792-7

Ejemplares similares